Dr. R. Revathi

Qualification
MS, DO
Designation
Chief, Cornea & Refractive Surgery Services
Active-Reg.No
Location
Aravind Eye Hospital, Coimbatore

Introduction

Dr. Revathi  graduated in medicine  and D.O Thanjavur Medical College, Thanjavur, M.S  from  Stanley Medical College, Chennai followed by Fellowship in Cornea at Aravind Eye Hospital, Madurai.

She started her career in Cornea and Refractive Surgery Services and Aravind IOB Eye Bank at Aravind Eye Hospital, Coimbatore.  She took part in many Clinical Trails including SCUT, MUTT 1 & 2.

Research & Publications

Dr. Revathi published 50 papers in National and International Peer Reviewed Journals.  She authored book chapters in Postgraduate Ophthalmology Zia & Vanathi.  She presented Scientific Papers, Posters and conducted Instruction Courses in AIOS, Keracon, EuCornea, ESCRS, WCC, ASCRS and AAO

  1. Prajna NV, Srinivasan M, Mascarenhas J, Lalitha P, Revathi R, McClintic SM, O’Brien KS, Ray KJ, Acharya NR, Lietman TM, Keenan JD. Visual impairment in fungal versus bacterial corneal ulcers four years after successful antimicrobial treatment. Am J Ophthalmol. 2019;204:124-129.
  2. Sharma N, Arora T, Singhal D, Maharana PK, Garg P, Nagpal R, Murthy S, Gunnam S, Arora A, Prajna NV, Revathi R, Padmanabhan P, Kumar A, Kumar R, Tomar S, Thomas A, Gyanchand R, Arora R, Biswas B, Basak S. Procurement, storage and utilization trends of eye banks in India. Indian J Ophthalmol. 2019;67:1056-1059.
  3. Palanisamy M, Abdel-hadi A, Singh YRB, Revathi R, Anita R, Banawas S, Dukhyil AAB, Alshehri B, Shobana CS, Selvam KP, Narendran V. Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of Fusarium and Aspergillus Isolates from Corneal Scrapings. BioMed Research International. 2019;2019:6395840.
  4. Cho J, Prajna NV, Lalitha, Prajna, Revathi R, Thiruvengada Krishnan, Lin, Y B, Ray, K J, Lietman, T M, Rose-Nussbaumer, J, Mycotic Ulcer Treatment Trial Group. Therapeutic Penetrating Keratoplasty Button Culture in the Mycotic Ulcer Treatment Trial II: a randomized trial comparing oral voriconazole vs placebo. Am. J. Ophthalmol. 2018 Aug;192:142-145.
  5. Oldenburg CE, Prajna NV, Thiruvengada Krishnan, Revathy, R, Srinivasan, M, Ray, K J, O’Brien, K S, Glymour, M M, Porco, T C, Acharya, N R, Rose-Nussbaumer, J, Lietman, T M. Regression Discontinuity and Randomized Controlled Trial Estimates: an application to the mycotic ulcer treatment trials. Ophthalmic Epidemiol. 2018;25:315-322.
  6. Ray KJ, Prajna, N Venkatesh, Lalitha, Prajna, Revathi R, Thiruvengada Krishnan, Patel, S, Mano Ranjan Das, Shah, R, Dhakhwa, K, McLeod, S D, Zegans, M E, Acharya, N R, Lietman, T M, Rose-Nussbaumer, J, Mycotic Ulcer Treatment Trial Group. The Significance of Repeat Cultures in the Treatment of Severe Fungal Keratitis. Am. J. Ophthalmol. 2018;189:41-46.
  7. Homa M, Manikandan, P, Saravanan, R, Revathi R, Anita Raghavan, Narendran, V, Panneerselvam, K, Shobana, C S, Aidarous, M A, Galgoczy, L, Vagvolgyi, C, Papp, T, Kredics, L.Exophiala Dermatitidis Endophthalmitis: case report and literature review. Mycopathologia. 2018;183:603-609.
  8. Anita R, Baidwal, S, Prabhu, V, Sakthi, R, Revathi R, Narendran, V, Sunitha, M, Rammohan R. Diagnostic Evaluation of Co-Occurrence Acanthamoeba and Fungi in Keratitis: a preliminary report. Cornea. 2018;37:227-234.
  9. Prajna NV, Thiruvengada Krishnan, Revathi R, Patel, S, Shah, R, Srinivasan, M, Mano Ranjan Das, Ray, K J, Oldenburg, C E, McLeod, S D, Zegans, M E, Acharya, N R, Lietman, T M, Rose-Nussbaumer, J, Mycotic Ulcer Treatment Trial Group. Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: a secondary analysis of the mycotic ulcer treatment trial II. JAMA Ophthalmol. 2017;135:987-991.
  10. Prajna NV, Thiruvengada Krishnan, Revathi R, Patel, S, Shah, R, Srinivasan, M, Lumbini Devi, Mano Ranjan Das, Ray, K J, O’Brien, K S, Oldenburg, C E, McLeod, S D, Zegans, M E, Acharya, N R, Lietman, T M, Rose-Nussbaumer, J, Mycotic Ulcer Treatment Trial Group. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: a secondary analysis from the mycotic ulcer treatment trial II. JAMA

Ophthalmol. 2017;135:520-525.

  1. Ray KJ, Lalitha, Prajna, Prajna, N Venkatesh, Revathi R, Thiruvengada Krishnan, Srinivasan, M, Ryg, R, McLeod, S, Acharya, N R, Lietman, T M, Rose-Nussbaumer, J, Mycotic Ulcer Treatment Trial. The Utility of Repeat Culture in Fungal Corneal Ulcer Management: a secondary analysis of the MUTT I randomized clinical trial group. Am. J. Ophthalmol. 2017;178:157-162.
  2. Panikkar K, George, J Manayath, Revathi R, Saravanan, V R. Progressive Kertoconus, Retinal Detachment, and Intracorneal Silicone Oil with Obsessive-Compulsive Eye Rubbing. Oman J Ophthalmol. 2016;9:170-173.
  3. Prajna NV, Thiruvengada Krishnan, Revathi R, Patel, S, Srinivasan, M, Mano Ranjan Das, Ray, K J, O’Brien, K S, Oldenburg, C E, McLeod, S D, Zegans, M E, Porco, T C, Acharya, N R, Lietman, T M, Rose-Nussbaumer, J, Mycotic Ulcer Treatmetn Trial II Group. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): a randomized clinical trial. JAMA Ophthalmol. 2016;134:1365-1372.
  4. Sun CQ, Prajna, N Venkatesh, Thiruvengada Krishnan, Revathi R, Srinivasan, M, Anita Raghavan, O’Brien, K S, McLeod, S D, Acharya, N R, Rose-Nussbaumer, J, Mycotic Ulcer Treatment Trial Group. Effect of Pretreatment with Antifungal Agents on Clinical Outcomes in Fungal Keratitis. Clin Experiment Ophthalmol. 2016;44:763-767016.
  5. Prajna NV, Lalitha, Prajna, Revathi R, Thiruvengada Krishnan, Anita Raghavan, Srinivasan, M, O’Brien, Kieran S, Zegans, Michael, McLeod, Stephen D, Acharya, Nisha R, Keenan, Jeremy D, Lietman, Thomas M, Rose-Nussbaumer, Jennifer, Mycotic Ulcer Treatment Trial Group. Changing Azole Resistance: a secondary analysis of the MUTT I randomized clinical trial. JAMA Ophthalmol. 2016;134:693-696.
  6. Rose-Nussbaumer J, Prajna, N Venkatesh, Thiruvengada Krishnan, Jeena Mascarenhas, Revathi R, Srinivasan, M, Anita Raghavan, Oldenburg, CE, O’Brien, K S, Ray, K J, Porco, T C, McLeod, S D, Acharya, N R, Keenan, J D, Lietman, T M, Mycotic Ulcer Treatment Trial Group. Risk Factors for Low Vision Related Functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole. Br J Ophthalmol. 2016;100:929-932.
  7. Rose-Nussbaumer J, Prajna, N Venkatesh, Thiruvengada Krishnan, Jeena Mascarenhas, Revathi R, Srinivasan, M, Anita Raghavan, Oldenburg, CE, O’Brien, K S, Ray, K J, McLeod, S D, Porco, T C, Lietman, T M, Acharya, N R, Keenan, J D, Mycotic Ulcer Treatment Trial I Group. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: a randomized clinical trial. JAMA Ophthalmol. 2015;133:642-646.
  8. Srinivasan M, Jeena Mascarenhas, Revathi R, Meenakshi, R, Lalitha, Prajna, Ray, Kathryn J, Zegans, Michael E, Acharya, Nisha R, Lietman, Thomas M, Keenan, Jeremy D. Visual Recovery in Treated Bacterial Keratitis. Ophthalmology. 2014;121:1310-1311.
  9. Revathi R, Parameshwar, B, Vikram, V, Sowmyalatha, M, Anita Raghavan, Siddharthan, S, Prajna, N Venkatesh. Topical 5 Percentage Natamycin with Oral Ketoconazole in Filamentous Fungal Keratitis: a randomized controlled trial. Asia Pac J Ophthalmol. 2015;4:146-50
  10. McClintic SM, Prajna, N Venkatesh, Srinivasan, M, Jeena Mascarenhas, Lalitha, Prajna, Revathi R, Oldenburg, C E, O’Brien, K S, Ray, K J, Acharya, N R, Lietman, T M, Keenan, J D.Visual Outcomes in Treated Bacterial Keratitis: four years of prospective follow-up. Invest. Ophthalmol. Vis. Sci. 2014;55:2935-2940.
  11. Ray KJ, Srinivasan, M, Jeena Mascarenhas, Revathi R, Meenakshi, R, Glidden, David V, Oldenburg, Catherine E, Sun, Catherine Q, Zegans, Michael E, McLeod, Stephen D, Acharya, Nisha R, Lietman, Thomas M. Early Addition of Topical Corticosteroids in the Treatment of Bacterial Keratitis. JAMA Ophthalmol. 2014;132:737-741.
  12. Siddharthan KS, Anita Raghavan, Revathi R. Clinical Features and Management of Ocular Lesions after Stings by Hymenopteran Insects. Indian J Ophthalmol. 2014;62:248-251.
  13. Sun CQ, Prajna, N Venkatesh, Thiruvengada Krishnan, Jeena Mascarenhas, Revathi R, Srinivasan, M, Anita Raghavan, O’Brien, K S, Ray, K J, McLeod, S D, Porco, T C, Acharya, N R, Lietman, T M. Expert Prior Elicitation and Bayesian Analysis of the Mycotic Ulcer Treatment Trial I. Invest. Ophthalmol. Vis. Sci. 2013;54:4167-4173.
  14. Oldenburg CE, Lalitha, Prajna, Srinivasan, M, Manikandan, P, Jayahar, M Bharathi, Revathi R, Meenakshi, R, Jeena Mascarenhas, Nardone, N, Ray, K J, Glidden, D V, Acharya, N R. Moxifloxacin Susceptibility Mediates the Relationship between Causative Organism and Clinical Outcome in Bacterial Keratitis. Invest. Ophthalmol. Vis. Sci. 2013;54:1522-1526.
  15. Srinivasan M, Jeena Mascarenhas, Revathi R, Meenakshi, R, Lalitha, Prajna, O’Brien, K S, Glidden, D V, Ray, K J, Oldenburg, C E, Zegans, M E, Whitcher, J P, McLeod, S D, Porco, T C, Lietman, T M, Acharya, N R, Steroids for Corneal Ulcers Trial Group. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial. Am. J. Ophthalmol. 2014;157:327-333.
  16. Prajna N Venkatesh, Srinivasan, M, Lalitha, Prajna, Thiruvengada Krishnan, Revathi R, Meenakshi, R, Jeena Mascarenhas, Oldenburg, C E, Ray, K J, McLeod, S D, Acharya, N R, Lietman, T M. Differences in Clinical Outcomes in Keratitis Due to Fungus and Bacteria. JAMA Ophthalmol.2013;131:1088-1089.
  17. Oldenburg CE, Lalitha, Prajna, Srinivasan, M, Revathi R, Meenakshi, R, Jeena Mascarenhas, Borkar, Durga S, Ray, Kathryn J, Zegans, Michael E, McLeod, Stephen D, Porcol, Travis C, Lietman, Thomas M, Acharya, Nisha R. Emerging Moxifloxacin Resistance in Pseudomonas Aeruginosa Keratitis Isolates in South India. Ophthalmic Epidemiol. 2013;20:155-158.
  18. Prajna NV, Thiruvengada Krishnan, Jeena Mascarenhas, Revathi R, Lalitha, Prajna, Srinivasan, M, Anita Raghavan, Oldenburg, Catherine E, Ray, Kathryn J, Zegans, Michael E, McLeod, Stephen D, Porco, Travis C, Acharya, Nisha R, Lietman, Thomas M, Mycotic Ulcer Treatment Trial Group. The Mycotic Ulcer Treatment Trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol.2013;131:422-429.
  19. Manikandan P, Varga, J, Kocsube, S, Anita Raghavan, Revathi R, Nemeth, T M, Narendran, V, Vagvolgyi, C, Panneer Selvam, K, Shobana, C S, Babu Singh, Y R, Kredics, L. Epidemiology of Aspergillus Keratitis at a Tertiary Care Eye Hospital in South India and Antifungal Susceptibilities of the causative Agents. Mycoses. 2013;56:26-33.
  20. Lalitha Prajna, Srinivasan, M, Revathi R, Meenakshi, R, Jeena Mascarenhas, Priya, J L, Sy, A, Oldenburg, C E, Ray, K J, Zegans, M E, McLeod, S D, Lietman, T M, Acharya, N R.Nocardia Keratitis: clinical course and effect of corticosteroids. Am. J. Ophthalmol. 2012;154:934-939.
  21. Jeena Mascarenhas, Srinivasan, M, Chen, M, Revathi R, Meenakshi, R, Lalitha, Prajna, Oldenburg, C E, Ray, K J, Glidden, D V, Costanza, S, Lietman, T M, Acharya, N R. Differentiation of Etiologic Agents of Bacterial Keratitis from Presentation Characteristics. Int Ophthalmol. 2012;32:531-8.
  22. Lalitha Prajna, Srinivasan, M, Manikandan, P, Jayahar, M Bharathi, Revathi R, Meenakshi, R, Cevallos, Vicky, Oldenburg, Catherine E, Ray, Kathryn J, Toutain-Kidd, Christine M, Glidden, David V, Zegans, Michael E, McLeod, Stephen D, Acharya, Nisha R, Lietman, Thomas M. Relationship of In Vitro Susceptibility to Moxifloxacin and In Vivo Clinical Outcome in Bacterial Keratitis. Clin Infect Dis. 2012;54:1381-7.
  23. Sy A, Srinivasan, M, Jeena Mascarenhas, Lalitha, Prajna, Revathi R, Meenakshi, R, Oldenburg, Catherine E, Ray, Kathryn J, Glidden, David, Zegans, Michael E, McLeod, Stephen D, Lietman, Thomas M, Acharya, Nisha R. Pseudomonas Aeruginosa Keratitis: outcomes and response to corticosteroid treatment. Invest. Ophthalmol. Vis. Sci. 2012;53:267-72.
  24. Srinivasan M, Jeena Mascarenhas, Revathi R, Meenakshi, R, Lalitha, Prajna, Glidden, David V, Ray, Kathryn J, Hong, Kevin C, Oldenburg, Catherine E, Lee, Salena M, Zegans, Michael E, McLeod, Stephen D, Lietman, Thomas M, Acharya, Nisha R, Steroids for Corneal Ulcers Trial Group. Corticosteroids for Bacterial Keratitis: the steroids for corneal ulcers trial (SCUT). Arch Ophthal. 2012;130:143-50.
  25. Srinivasan M, Jeena Mascarenhas, Revathi R, Meenakshi, R, Lalitha, Prajna, Glidden, David V, Ray, Kathryn J, Hong, Kevin C, Oldenburg, Catherine E, Lee, Salena M, Zegans, Michael E, McLeod, Stephen D, Lietman, Thomas M, Acharya, Nisha R. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics for the steroids for corneal ulcers trial group. Arch Ophthal. 2012;130:151-7.
  26. Oldenburg CE, Sy, Aileen, Srinivasan, M, Toutain-Kidd, Christine M, Jeena Mascarenhas, Meenakshi, R, Revathi R, Esterberg, Elizabeth J, Chidambaram, Jaya D, Acharya, Nisha R, Lietman, Thomas M, Zegans, Michael E.Pre-Existing Blindness in a Cohort of Patients with Bacterial Keratitis. Br J Ophthalmol. 2011;95:1612-1613.
  27. Manikandan P, Varga, Janos, Kocsube, Sandor, Revathi R, Anita Raghavan, Doczi, Ilona, Nemeth, Tibor M, Narendran, V, Vagvolgyi, Csaba, Bhaskar, Madhavan, Manoharan, Chockaiya, Samson, Robert A, Kredics, Laszlo. Keratitis caused by the Recently Described New Species Aspergillus Brasiliensis: two case reports. J Med Case Reports. 2010;4:68.
  28. Kredics L, Varga, Janos, Kocsube, Sandor, Revathi R, Anita Raghavan, Doczi, Ilona, Bhaskar, Madhavan, Nemeth, Tibor Mihaly, Antal, Zsuzsanna, Narendran, V, Vagvolgyi, Csaba, Samson, Robert A,  Chockaiya, Manoharan, Manikandan, P. Infectious Keratitis caused by Aspergillus Tubingensis. Cornea. 2009;28:951-954.
  29. Manikandan P, Varga, Janos, Kocsube, Sandor, Samson, Robert A, Anita Raghavan, Revathi R. Doczi, Ilona, Nemeth, Tibor Mihaly, Narendran, V, Vagvolgyi, Csaba, Manoharan, Chockaiya, Kredics, Laszlo. Mycotic Keratitis Due to Aspergillus Nomius. J Clin Microbiol. 2009;47:3382-3385.
  30. Acharya Nisha R, Srinivasan, M, Jeena Mascarenhas, Meenakshi, R, Revathi R, Zegans, Michael, McLeod, Stephen, Lietman, Thomas M. The Steroid Controversy in Bacterial Keratitis. Arch Ophthal. 2009;127:1231.
  31. Revathi R, Satinderpal Singh, Anita Raghavan, Amar Karkhanis. Efficacy and Safety of Intracameral Perfluoropropane (C3F8) Tamponade and Compression Sutures for the Management of Acute Corneal Hydrops. Cornea. 2009;28:317-320.
  32. Manikandan P, Vismer HF, Kredics L, Doczi I, Marasas W F, Bhaskar M, Anita Raghavan, Revathi R, Narendran V. Corneal Ulcer Due to Neocosmospora Vasinfecta in an Immunocompetent Patient. Med Mycol. 2008;46:279-284.
  33. Gurdeep Singh, Revathi R, Anita Raghavan, Manikandan P. Bilateral Conjunctival Retention Cysts in the Aftermath of Stevens-Johnson Syndrome. Indian J Ophthalmol. 2008;56:70-72.
  34. Kredics L, Varga J, Kocsube S, Doczi I, Samson R A, Revathi R, Narendran V, Bhaskar M, Vagvolgyi C, Manikandan P. Case of Keratitis caused by Apergillus tamarii. J. Clin. Microbiol. 2007;45:3464-3467.
  35. Revathi R, Thomson S. Multiple Foreign Body Injury. Ophthalmic Photography. 2007;29:32-33.
  36. Revathi R, Sachin Mathew George, Anita Raghavan. Ocular Indigo Dye Injury. Cornea. 2006;25:1248-1250.
  37. Manikandan P, Bhaskar M, Revathi R, John Rajesh K, Kalpana Narendran, Narendran V. Speciation of Coagulase Negative Staphylococcus causing Bacterial Keratitis. Indian J Ophthalmol. 2005;53:59-60.
  38. Manikandan P, Bhaskar M, Revathi R, Rajesh Kumr John, Narendran V, Panneerselvam K. Acanthamoeba Keratitis – A Six Year Epidemiological Review from a Tertiary Care Eye Hospital in South India. Indian J Med Microbiol. 2004;22:226-230.